Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

"Ultrasensitive Reactive C-Protein As an Affordable Biomarker of Quantitative Expression of the BCR-ABL Transcript in Chronic Myeloid Leukemia. an Exploratory Study."

Luis Villela, MD, Melani Otañez Arce, MD, Carlos Best, MD, Alicia Guzman, MD, Elva Gabriela Estrada, MD, Laura Rivera Mendoza, MD, Juan Carlos Lopez Hernandez, MD, Arianna Robles, MD, David Gomez-Almaguer, MD

Blood (2018) 132 (Supplement 1): 5450.

https://doi.org/10.1182/blood-2018-99-119356

Published: 2018

Journal Articles

Molecular Subtype Classification of Diffuse Large B-Cell Lymphoma By Immunohistochemical Algorithms and Automatic Supervised Classifiers

Yocanxóchitl Perfecto-Avalos, PhD, Luis Villela, MD, Alejandro Garcia-Gonzalez, PhD, Ana G. Hernández-Reynoso, MS, Gildardo Sánchez-Ante, PhD, Rita Q. Fuentes-Aguilar, PhD, Sean Scott, PhD, Carlos Ortiz-Hidalgo, MD, Jose Borbolla Escoboza, MD

Blood (2016) 128 (22): 4229.

https://doi.org/10.1182/blood.V128.22.4229.4229

Published: 2016

Journal Articles

GPX3 Level in Serum of Diffuse Large B Cell Lymphoma Patients Is a Predictive Biomarker for Refractoriness Before Treatment

Luis Villela, MD, Oscar Fajardo, MSc, Darinka Leon, MD, Jose A Hernandez-Hernandez, PhD, Sean Scott, PhD, Sergio Encarnacion, PhD

Blood (2012) 120 (21): 5102.

https://doi.org/10.1182/blood.V120.21.5102.5102

Published: 2012

Journal Articles

Mutations In Circadian Rhythm Genes Are Associated with Diffuse Large B-Cell Lymphoma In the Mexican Population

Miguel Ángel Gutiérrez-Monreal, MSc, Luis Villela, MD, Yocanxochitl Perfecto, MSc, Samuel Kettenhofen, Guy Cardineau, PhD, Severiano Baltazar, MD, Job Cortez, MD, Sean-Patrick Scott, PhD

Blood (2010) 116 (21): 2478.

https://doi.org/10.1182/blood.V116.21.2478.2478

Published: 2010

Journal Articles

Primary Prophylaxis Using Peg-Filgrastim Is Useful Preventing Severe Infections and Neutropenia in Patients Diagnosed with Non Hodgkin Lymphoma (NHL). Report of Latin America International Multicenter Study

Luis Villela, MD, Alberto Villalobos, MD, Gustavo Reyes-Brena, MD, Jorge Duque, MD, Juan Carlos Solís-Poblano, Eduardo Reynoso, MD, Roberto Ovilla, MD, Alejandro Camacho, MD, Norberto Vazquez, MD, Oscar Garces, Enrique Pedrasa, MD, Salvador Silva, MD

Blood (2008) 112 (11): 4663.

https://doi.org/10.1182/blood.V112.11.4663.4663

Published: 2008

Journal Articles

Efficacy and Safety of Rituximab+CHOP in IR and Maintenance Therapy with Rituximab vs Observation in De Novo Aggressive Non-Hodgkin Lymphoma.

Francisco Tripp, MD, Enrique Báez, MD, Elsa Ávila, MD, Severiano Baltazar, MD, Oscar Garcés, MD, Gustavo Reyes, MD, Benjamín Batista, MD, Alva Zaragoza, MD, Jorge Vela-Ojeda, MD, Luis Villela, MD

Blood (2007) 110 (11): 4489.

https://doi.org/10.1182/blood.V110.11.4489.4489

Published: 2007

Journal Articles

Safety of Intrathecal Rituximab as Prophylaxis or Treatment in CD20+ Acute Lymphoblastic and Aggressive Lymphoma: Report from a Mexican Pilot Study.

Luis Villela, MD, Rocio Caballero-Caballero, MD, Josefa Piedras-Ross, Hetor Garcia-Herrera, MD, Dolores Mejia, MD, Jose R. Borbolla Escoboza, MD

Blood (2006) 108 (11): 4713.

https://doi.org/10.1182/blood.V108.11.4713.4713

Published: 2006

Journal Articles

International Staging System Is Useful for Predicting Survival in Patients with Multiple Myeloma Treated with Chemotherapy ± Interferon vs Intensive Treatment.

Luis Villela, MD, Agustin Avilés-Miranda, MD, Manuel A. López-Hernández, MD, Maria J. Nambo, MD, José R. Borbolla-Escoboza, MD

Blood (2005) 106 (11): 5177.

https://doi.org/10.1182/blood.V106.11.5177.5177

Published: 2005

Journal Articles

Parvovirus B19 and Aplastic Anemia: Case Control Study: Preliminary Report from the ITESM Hematology Study Group.

Jose R. Borbolla Escoboza, MD, Marcos E. Garza-Madrid, MD, Luis Villela, MD, Manuel A. Lopez-Hernandez, MD, Jorge Vela-Ojeda, MD

Blood (2005) 106 (11): 3765.

https://doi.org/10.1182/blood.V106.11.3765.3765

Published: 2005

NARROW

"Ultrasensitive Reactive C-Protein As an Affordable Biomarker of Quantitative Expression of the BCR-ABL Transcript in Chronic Myeloid Leukemia. an Exploratory Study."

Molecular Subtype Classification of Diffuse Large B-Cell Lymphoma By Immunohistochemical Algorithms and Automatic Supervised Classifiers

GPX3 Level in Serum of Diffuse Large B Cell Lymphoma Patients Is a Predictive Biomarker for Refractoriness Before Treatment

Mutations In Circadian Rhythm Genes Are Associated with Diffuse Large B-Cell Lymphoma In the Mexican Population

Primary Prophylaxis Using Peg-Filgrastim Is Useful Preventing Severe Infections and Neutropenia in Patients Diagnosed with Non Hodgkin Lymphoma (NHL). Report of Latin America International Multicenter Study

Efficacy and Safety of Rituximab+CHOP in IR and Maintenance Therapy with Rituximab vs Observation in De Novo Aggressive Non-Hodgkin Lymphoma.

Safety of Intrathecal Rituximab as Prophylaxis or Treatment in CD20+ Acute Lymphoblastic and Aggressive Lymphoma: Report from a Mexican Pilot Study.

International Staging System Is Useful for Predicting Survival in Patients with Multiple Myeloma Treated with Chemotherapy ± Interferon vs Intensive Treatment.

Parvovirus B19 and Aplastic Anemia: Case Control Study: Preliminary Report from the ITESM Hematology Study Group.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only